New to this message board but a long term holder of Biota in Australia and looking forward to exciting prospects now we have moved to NASDAQ. The Influenza antivirals are obviously the flagship products but also a range of other well advanced products in the pipeline. Currently undervalued.
Regards
Kangaroo